Biotech M&A boom sees Sanofi snapping up Ablynx 9:37pm IST - 01:01 
French drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock reports.   
French drugmaker Sanofi agrees to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. Amy Pollock reports.  //reut.rs/2nmgPqA